Literature DB >> 29696632

Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice.

Gar Yee Koh1, Anne Kane2, Kyongbum Lee3, Qiaobing Xu3,4,5, Xian Wu1, Jatin Roper5, Joel B Mason1,5,6, Jimmy W Crott1.   

Abstract

Gut dysbiosis may play an etiological role in colorectal tumorigenesis. We previously observed that the abundance of Parabacteroides distasonis (Pd) in stool was inversely associated with intestinal tumor burden and IL-1β concentrations in mice. Here, we assessed the anti-inflammatory capacity of Pd membrane fraction (PdMb) in colon cancer cell lines. In addition, we tested whether Pd could suppress colon tumorigenesis in mice. Six-week-old male A/J mice were fed a low-fat (LF) diet, high-fat (HF) diet or HF+ whole freeze-dried Pd (HF + Pd, 0.04% wt/wt) for 24 weeks. After 1 week on diet, mice received 4 weekly injections of azoxymethane. PdMb robustly suppressed the production of pro-inflammatory cytokines and lowered the abundance of MyD88 and pAkt (ser473) induced by E. coli lipopolysaccharide in colon cancer cell lines. Moreover, PdMb induced apoptosis in colon cancer cell lines and blocked TLR4 activation in a reporter line. Colon tumors were observed in 0% of LF (0 of 19), 25% of HF (5 of 20) and 0% of HF + Pd mice (0 of 20) (p = 0.005). The latter group also displayed a lower abundance of MyD88 and pAkt (ser473) in colonic mucosa than HF mice. Taken together, these data suggest that Pd has anti-inflammatory and anti-cancer properties that are likely mediated by the suppression of TLR4 and Akt signaling, as well as promotion of apoptosis. Further work is needed to confirm these findings in additional models and fully elaborate the mechanism of action.
© 2018 UICC.

Entities:  

Keywords:  Parabacteroides distasonis; colorectal cancer; inflammation; protein kinase B; toll-like receptor 4

Mesh:

Substances:

Year:  2018        PMID: 29696632     DOI: 10.1002/ijc.31559

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

1.  Disruption of Genes Encoding Putative Zwitterionic Capsular Polysaccharides of Diverse Intestinal Bacteroides Reduces the Induction of Host Anti-Inflammatory Factors.

Authors:  Kathleen L Arnolds; Eiko Yamada; C Preston Neff; Jennifer M Schneider; Brent E Palmer; Catherine A Lozupone
Journal:  Microb Ecol       Date:  2022-05-21       Impact factor: 4.552

2.  Pathways and microbiome modifications related to surgery and enterocolitis in Hirschsprung disease.

Authors:  Roberto Biassoni; Eddi Di Marco; Stefano Avanzini; Alessio Pini Prato; Margherita Squillario; Elisabetta Ugolotti; Manuela Mosconi; Maria Grazia Faticato; Girolamo Mattioli
Journal:  Pediatr Surg Int       Date:  2021-10-22       Impact factor: 1.827

3.  Partially hydrolyzed guar gum alleviates hepatic steatosis and alters specific gut microbiota in a murine liver injury model.

Authors:  Takayuki Fujii; Haruyuki Nakayama-Imaohji; Aya Tanaka; Hiroto Katami; Kazuya Tanaka; Yoichi Chiba; Machi Kawauchi; Masaki Ueno; Tomomi Kuwahara; Ryuichi Shimono
Journal:  Pediatr Surg Int       Date:  2022-09-12       Impact factor: 2.003

4.  Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer.

Authors:  Laura W Bowers; Elaine M Glenny; Arunima Punjala; Nadia A Lanman; Audrey Goldbaum; Caroline Himbert; Stephanie A Montgomery; Peiying Yang; Jatin Roper; Cornelia M Ulrich; Andrew J Dannenberg; Michael F Coleman; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2022-08-01

5.  Recombinant Bifidobacterium longum Carrying Endostatin Protein Alleviates Dextran Sodium Sulfate-Induced Colitis and Colon Cancer in Rats.

Authors:  Zhiqian Bi; Enqing Cui; Yingying Yao; Xiaoyao Chang; Xiaoyang Wang; Yuhui Zhang; Gen-Xing Xu; Hongqin Zhuang; Zi-Chun Hua
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

Review 6.  How Diet and Physical Activity Modulate Gut Microbiota: Evidence, and Perspectives.

Authors:  Daniela Campaniello; Maria Rosaria Corbo; Milena Sinigaglia; Barbara Speranza; Angela Racioppo; Clelia Altieri; Antonio Bevilacqua
Journal:  Nutrients       Date:  2022-06-14       Impact factor: 6.706

7.  Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU.

Authors:  Zhanhuai Wang; Lindsay M Hopson; Stephanie S Singleton; Xiaochun Yang; Wilma Jogunoori; Raja Mazumder; Vincent Obias; Paul Lin; Bao-Ngoc Nguyen; Michael Yao; Larry Miller; Jon White; Shuyun Rao; Lopa Mishra
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-05-31       Impact factor: 5.187

8.  Dietary Rice Bran-Modified Human Gut Microbial Consortia Confers Protection against Colon Carcinogenesis Following Fecal Transfaunation.

Authors:  Kristopher D Parker; Akhilendra K Maurya; Hend Ibrahim; Sangeeta Rao; Petronella R Hove; Dileep Kumar; Rama Kant; Bupinder Raina; Rajesh Agarwal; Kristine A Kuhn; Komal Raina; Elizabeth P Ryan
Journal:  Biomedicines       Date:  2021-02-03

Review 9.  Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health.

Authors:  Jessica C Ezeji; Daven K Sarikonda; Austin Hopperton; Hailey L Erkkila; Daniel E Cohen; Sandra P Martinez; Fabio Cominelli; Tomomi Kuwahara; Armand E K Dichosa; Caryn E Good; Michael R Jacobs; Mikhail Khoretonenko; Alida Veloo; Alexander Rodriguez-Palacios
Journal:  Gut Microbes       Date:  2021 Jan-Dec

10.  Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions.

Authors:  Lorenzo Polimeno; Michele Barone; Adriana Mosca; Maria Teresa Viggiani; Farahnaz Joukar; Fariborz Mansour-Ghanaei; Sara Mavaddati; Antonella Daniele; Lucantonio Debellis; Massimo Bilancia; Luigi Santacroce; Alfredo Di Leo
Journal:  Microorganisms       Date:  2020-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.